Sandler Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-125,760
Closed -$9.98M 156
2019
Q1
$9.98M Buy
+125,760
New +$9.41M 0.78% 58
2018
Q3
Sell
-262,000
Closed -$15.2M 139
2018
Q2
$15.2M Buy
+262,000
New +$14.8M 1.27% 30

Other funds holding MRK

Sandler Capital Management's MRK Position: Q1 2026 in Review

Sandler Capital Management sold out of Merck (MRK) in Q1 2026, closing a stake of 27,900 shares — an estimated $2.94M sold.

Sandler Capital Management first reported a position in MRK in Q4 2018 and held it in 9 quarters. The position peaked at $2.94M in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sandler Capital Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Sandler Capital Management sold 27,900 Merck shares in Q1 2026, an estimated $2.94M.
  • Sandler Capital Management first reported a position in Merck in Q4 2018 and held it in 9 quarters.
  • Sandler Capital Management's Merck position peaked at $2.94M in Q4 2025.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sandler Capital Management's 13F filing for Q1 2026, filed 15 May 2026.